For Immediate Release
Jul 3, 2013
Contact : Maureen Gillespie, Public Relations Manager
Alexander Shifrin, M.D., FACS, FACE, Endocrine Surgeon at Jersey Shore University Medical Center, will present at the 2nd World Congress on Thyroid Cancer in Toronto, Canada
Neptune, NJ - Alexander Shifrin, M.D., FACS, FACE, Endocrine Surgeon at Jersey Shore, will present at the 2nd World Congress on Thyroid Cancer, taking place July 10 through July 14, 2013 in Toronto, Canada. Dr. Shifrin’s oral presentation, entitled Assessment of Molecular Markers on Preoperative FNA Biopsies of Metastatic Lymph Nodes from Differentiated Thyroid Carcinoma and Correlation with the Primary Thyroid Tumor: The Feasibility Study, is scheduled to take place during the conference on Friday, July 12 from 10:30 a.m. to 12 p.m.
The 2nd World Congress on Thyroid Cancer is a global multi-disciplinary meeting of specialists involved in the field of thyroid cancer, and covers the entire spectrum of thyroid nodules and thyroid cancer. The congress program focuses on the most recent advances in this field, and appeals to a broad audience of specialists. The scientific program includes keynotes, lectures, panels, workshops, instructional courses, video sessions, auxiliary symposiums, and scientific and commercial exhibits.
Dr. Shifrin’s presentation will focus on a new diagnostic evaluation of patients with advanced metastatic thyroid cancer that has spread to the lymph nodes. The assessment of metastatic lymph nodes for molecular markers may help in a diagnosis, and also may help to determine the most effective treatment plan for patients.
According to Mark Krasna, M.D., corporate medical director of oncology, Meridian Cancer Care, “Dr. Shifrin’s participation in the 2nd World Congress on Thyroid Cancer confirms his role as an innovator in the field of thyroid disease. The conference provides a global platform for Dr. Shifrin to share his work with other thyroid experts, and will ultimately lead to improved care and treatment for patients suffering from thyroid disease.”
Meridian Cancer Care provides highly personalized, advanced care from a remarkable team of cancer experts who work together to create the most effective treatment plan for each patient. Meridian Cancer Care’s multidisciplinary approach includes the latest breakthroughs in surgery, technology and radiation therapy, genetic counseling, state-of-the-art diagnostics and clinical trials of tomorrow’s most promising treatments.
About Jersey Shore University Medical Center:
Jersey Shore University Medical Center, a member of the Meridian Health family, is a not-for-profit teaching hospital and home to K. Hovnanian Children’s Hospital – the first children’s hospital in Monmouth and Ocean counties. Jersey Shore is the regional provider of cardiac surgery, a program which has been ranked among the best in the Northeast, and is home to the only trauma center and stroke rescue center in the region. Jersey Shore University Medical Center specializes in cardiovascular care, orthopedics and rehabilitation, cancer care, neuroscience, and women’s specialty services. For more information on Jersey Shore University Medical Center call 1-800-DOCTORS, or visit www.JerseyShoreUniversityMedicalCenter.com.